Table 5.
APP/PS1 | APP/PS1+LF | APP/PS1+HF | ||||
---|---|---|---|---|---|---|
Male | Female | Male | Female | Male | Female | |
BACE1 | 0.51 ± 0.20 | 0.49 ± 0.40 | 0.70 ± 0.30 | 0.62 ± 0.25 | 0.77 ± 0.20 | 0.80 ± 0.75 |
ADAM10 | 0.53 ± 0.20 | 0.47 ± 0.10 | 0.24 ± 0.10 | 0.36 ± 0.15 | 0.30 ± 0.20 | 0.23 ± 0.25 |
BACE2 | 0.43 ± 1.10 | 0.57 ± 0.75 | 0.44 ± 1.20 | 0.54 ± 0.90 | 0.37 ± 0.35 | 0.46 ± 0.50 |
SNAP-25 | 0.43 ± 0.10 | 0.57 ± 0.10 | 0.50 ± 0.95 | 0.41 ± 0.15 | 0.28 ± 0.30 | 0.37 ± 0.25 |
SYP | 0.54 ± 0.15 | 0.46 ± 0.15 | 0.36 ± 0.10 | 0.46 ± 0.10 | 0.33 ± 0.05 | 0.29 ± 0.10 |
Notice: APP/PS1, amyloid precursor protein/presenilin 1; LF, lower fluoride; HF, high fluoride. The values shown are means ± SD (n = 5) as determined by analysis of variance (ANOVA), followed by the least significant differences post hoc test